Orion Capital Management’s AbbVie ABBV Stock Holding History

Orion Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.77M	Sell	8,129 -931	-10%	-$207K	0.61%	27
2025 Q4	$2.07M	Buy	9,060 +8	+0.1%	+$1.82K	0.7%	25
2025 Q3	$2.1M	Buy	9,052 +5	+0.1%	+$1.02K	0.73%	26
2025 Q2	$1.68M	Buy	9,047 +11	+0.1%	+$2.04K	0.64%	28
2025 Q1	$1.89M	Buy	9,036 +5,181	+134%	+$1.01M	0.8%	24
2024 Q4	$685K	Hold	3,855	–	–	0.3%	59
2024 Q3	$761K	Buy	3,855 +90	+2%	+$16.8K	0.37%	56
2024 Q2	$646K	Buy	3,765 +50	+1%	+$8.28K	0.34%	56
2024 Q1	$677K	Hold	3,715	–	–	0.36%	55
2023 Q4	$576K	Sell	3,715 -150	-4%	-$21.9K	0.34%	58
2023 Q3	$576K	Sell	3,865 -895	-19%	-$131K	0.37%	56
2023 Q2	$641K	Buy	4,760 +100	+2%	+$14.7K	0.42%	54
2023 Q1	$743K	Sell	4,660 -358	-7%	-$54.7K	0.5%	44
2022 Q4	$811K	Hold	5,018	–	–	0.59%	43
2022 Q3	$673K	Buy	5,018 +608	+14%	+$87.2K	0.54%	45
2022 Q2	$675K	Sell	4,410 -1,000	-18%	-$153K	0.52%	42
2022 Q1	$877K	Hold	5,410	–	–	0.53%	45
2021 Q4	$733K	Hold	5,410	–	–	0.42%	56
2021 Q3	$584K	Hold	5,410	–	–	0.35%	63
2021 Q2	$609K	Hold	5,410	–	–	0.38%	58
2021 Q1	$585K	Buy	5,410 +1,410	+35%	+$151K	0.41%	55
2020 Q4	$429K	Buy	+4,000	New	+$384K	0.32%	63

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Orion Capital Management's ABBV Position: Q1 2026 in Review

Orion Capital Management reduced its AbbVie (ABBV) stake by 10% in Q1 2026, selling an estimated $207K and leaving 8,129 shares worth $1.77M. The position accounts for 0.61% of the portfolio, ranked #27.

Orion Capital Management first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.1M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Orion Capital Management held 8,129 shares of AbbVie worth $1.77M as of Q1 2026.
Orion Capital Management sold 931 AbbVie shares in Q1 2026, an estimated $207K.
AbbVie made up 0.61% of Orion Capital Management's portfolio in Q1 2026, its #27 holding.
Orion Capital Management first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
Orion Capital Management's AbbVie position peaked at $2.1M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Orion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.